Compass Pathways Plc's ROA from the third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Compass Pathways Plc's ROA in the third quarter of 2026?
Compass Pathways Plc recorded a cumulative net loss of $-266 million during 12 months ending in the third quarter of 2026, resulting in a negative return on assets (ROA) of -59.95%.

However, within the Healthcare sector 615 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 30 2026 quarter, so far to 4009, from total ROA ranking in the second quarter of 2026 at 5008.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Total Assets Change	106.51 %	74.95 %	68.22 %	-0.17 %	2.49 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-266	-394	-179	-288	-237
Return On Assets (TTM)	-59.95 %	-104.58 %	-55.42 %	-107.33 %	-88.45 %
CMPS's Total Ranking	# 4009	# 5008	# 4373	# 4122	# 4205
Total Assets (TTM) in million	522	507	537	211	253
Seq. Total Assets Change	2.89 %	-5.48 %	153.97 %	-16.39 %	-12.83 %
Seq. Net Income Change	-	-	-	-	-

CMPS's 5 Years Annual ROA >> Back to CMPS Management Effectiveness >> Compare CMPS ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 275
Sector	# 616
Overall	# 4018

Return On Assets Statistics
High	Average	Low
-29.65 %	-55.8 %	-106.75 %
(Dec 31 2020)		(Dec 31 2025)

Financial Statements
Compass Pathways Plc's Assets	$ 522 million	CMPS's Balance sheet
Compass Pathways Plc's Income	$ -10 million	Quarterly CMPS's Income Statement
CMPS's Income by Division		See CMPS's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	-0.17 %	-22.84 %	10.42 %	-17.22 %	37.74 %
Total Assets in million	211	212	274	248	300
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-288	-155	-118	-92	-72
Annual Return On Assets	-136.25 %	-73.3 %	-43.19 %	-36.84 %	-23.91 %

CMPS's 5 Years Annual ROA >> Back to CMPS Management Effectiveness >> Compare CMPS ROA to its Competitors

More Return On Assets Ratios
CMPS's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
CMPS's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for CMPS's Competitors
Subscribers only: Roa for Compass Pathways Plc's Suppliers
Subscribers only: Return On Assets for CMPS's Customers

You may also want to know
CMPS's Roi	CMPS's Inventory Turnover Ratio	CMPS's Growth Rates	CMPS's Dividend Comparisons
	CMPS's Profitability Ratios	CMPS's Asset Turnover Ratio	CMPS's Dividend Growth
CMPS's Roe	CMPS's Valuation Ratios	CMPS's Financial Strength Ratios	CMPS's Dividend Payout Ratio

Companies with similar Return On Assets at Sep 30 2026, within Healthcare Sector

ROA

Date modified: 2026-11-04T15:09:33+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.